Combination antifungal therapy: from bench to bedside
B Wirk, JR Wingard - Current infectious disease reports, 2008 - Springer
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Combination antifungal therapy: From bench to bedside
B Wirk, JR Wingard - Current Fungal Infection Reports, 2008 - Springer
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Combination antifungal therapy: From bench to bedside
B Wirk, JR Wingard - Current Infectious Disease Reports, 2008 - search.proquest.com
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Combination antifungal therapy: from bench to bedside
B Wirk, JR Wingard - Current infectious disease reports, 2008 - pubmed.ncbi.nlm.nih.gov
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Combination antifungal therapy: from bench to bedside.
B Wirk, JR Wingard - 2008 - cabidigitallibrary.org
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Combination antifungal therapy: From bench to bedside
B Wirk, JR Wingard - Current Infectious Disease Reports, 2008 - pure.psu.edu
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …
[PDF][PDF] Combination Antifungal Therapy: From Bench to Bedside
B Wirk, JR Wingard - Current Infectious Disease …, 2008 - awarticles.s3.amazonaws.com
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Combination antifungal therapy: from bench to bedside.
B Wirk, JR Wingard - Current Infectious Disease Reports, 2008 - europepmc.org
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Combination antifungal therapy: From bench to bedside
B Wirk, JR Wingard - Current Fungal Infection Reports, 2008 - infona.pl
Invasive fungal infections are major causes of mortality in immunocompromised patients.
Despite improved outcomes with new antifungals, there remains a pressing need to further …
Despite improved outcomes with new antifungals, there remains a pressing need to further …